Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON35863
NL-OMON35863
Withdrawn
Phase 4

Improving preconceptional glycaemic regulation using RealTime Continuous Glucose Monitoring in women with type 1 diabetes who have *acceptable but not optimal* HbA1c values: an observational study - Improving preconceptional glucose regulation in DM1women using RT-CGMS

Academisch Medisch Centrum0 sites10 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Academisch Medisch Centrum
Enrollment
10
Status
Withdrawn
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- diagnosed with diabetes mellitus 1 at least for one year diagnosis
  • •\- insulin pump for at least 3 months
  • •\- reliable performance of SMBG at least 5 times a day for at least 5 days a week
  • •\- child wish
  • •\- stable HbA1c 43\-53 mmol/mol: the last 2 values \+/\- 3 mmol/mol
  • •\- willing to (patient herself) and capable of (as estimated by treating doctor) using RT\-CGMS
  • •\- able to read and speak Dutch
  • •\- written informed consent
  • •\- internet access (uploading results sensor)

Exclusion Criteria

  • •\- co\-existent medical problems that would interfere with study participation
  • •\- use of medication that could influence glycaemic control (for example corticosteroids) in last three months

Outcomes

Primary Outcomes

Not specified

Similar Trials

Withdrawn
Phase 4
Improving preconceptional suboptimal glycaemic control in type 1 diabetes using RealTime Continuous Glucose Monitoring: a randomised trialDiabetesDiabetes Mellitus10018424
NL-OMON36232Academisch Medisch Centrum20
Suspended
Not Applicable
Improving preconceptional suboptimal glycaemic control in type 1 diabetes using RealTime Continuous Glucose Monitoring (RT-CGMS): A Randomised Clinical Trial.”- preconceptional- real-time- glucose monitoring- diabetes type 1
NL-OMON26973Sponsor: University Medical Center Utrecht (UMCU) Adress: Heidelberglaan 100 postal code: 3584 CX city: Utrecht country: The Netherlands phone: +31 (0)88 75 555 55 email: info@umcutrecht.nl Postadres:Postbus 85500 3508 GA Utrecht20
Completed
Not Applicable
Improving Postprandial Glycaemia by a New Developed Closed-loop Control System - Closedloop4mealsDiabetes Mellitus, Type 1
NCT02100488Fundación para la Investigación del Hospital Clínico de Valencia20
Not yet recruiting
Not Applicable
Optimising glycaemic control in paediatric patients on insulin pump therapy: impact of glycaemic load and bolus wave type on postprandial glycaemiaType 1 Diabetes MellitusMetabolic and Endocrine - Diabetes
ACTRN12605000762651Royal Children's Hospital, Parkville, Vic 3052.36
Recruiting
Not Applicable
Investigating glycemic controls achieved in one year after discharge among type2 diabetic inpatients who received semaglutide via protecting beta-cell function.type2 diabetes
JPRN-UMIN000042481Saiseikai Yokohamashi Nanbu Hospital80